Загрузка...
Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers
Nolasiban is an orally active oxytocin receptor antagonist being developed to increase the efficiency of assisted reproductive technologies. This study evaluated the pharmacokinetics, pharmacodynamics, and cardiac safety of nolasiban in 45 healthy women of child-bearing age. Nolasiban was administer...
Сохранить в:
| Опубликовано в: : | Sci Rep |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7973531/ https://ncbi.nlm.nih.gov/pubmed/33739022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85650-3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|